ArticleACS medicinal chemistry letters2019

Discovery of a Potent and Selective TRPC5 Inhibitor, Efficacious in a Focal Segmental Glomerulosclerosis Model.

Maolin Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.